Saturday, March 24, 2012

Updates on Canadian Sandoz drug shortage from HPCO

A provincial stakeholders group has been formed with representation from all areas within hospice palliative care.  A conference call is also held every Monday, Wednesday, and Friday with MOHLTC and the MOHLTC Emergency Operations Centre (EOC) to update all parties.  HPCO is represented by HPCO board member Elaine Klym who is the Director of Care at Maison Vale Hospice in Sudbury.

Processes have been established to report drug shortages within hospice palliative care settings. Reporting is segmented by care setting with community health service providers reporting shortages to their respective associations daily. The associations compile the reports and forward them to the Emergency Operations Centre at 2:00 PM daily.

  •   Community Care Access Centres report to the Ontario Association of Community Care Access Centres
  •   Home care organizations report to the Ontario Home Care Association
  •   Long-term care organizations report to the Ontario Long-Term Care Association or the Ontario Association of Non-Profit Homes and Services for Seniors
  •   Hospices report to Hospice Palliative Care Ontario
All operating Residential Hospices must now report shortages to HPCO by 1:30 PM daily so that we may compile the reports and forward them to the Emergency Operations Centre (EOC) by 2:00 PM.  An advisory has been sent to all Residential Hospice directors with details on the report procedure and template.

MOHLTC has tasked HPCO with developing a policy on medication return and retention within Residential Hospices. This will permit Residential Hospices to retain drugs in an on-site inventory when a client dies rather than returning the drugs for disposal.  A task group headed by Elaine Klym is drafting the policy for distribution by Friday, March 23. Since all Residential Hospices have drug inventory control policies and procedures in place implementation of a drug retention policy should be relatively straight forward.

The feedback from today?s stakeholder conference call was that in the in-home setting (patient?s  individual home) there is no way of maintaining quality of the medication once it has left the pharmacy so this medication must continue to be destroyed.

HPCO will continue to update members as information becomes available.

Rick Firth
Executive Director
Hospice Palliative Care Ontario
rfirth@hpco.ca

No comments: